NATIONAL BANK OF CANADA /FI/ - INMED PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

INMED PHARMACEUTICALS INC's ticker is and the CUSIP is 457637601. A total of 15 filers reported holding INMED PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
NATIONAL BANK OF CANADA /FI/ ownership history of INMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$13
+18.2%
20
+66.7%
0.00%–
Q2 2023$11
-15.4%
120.0%0.00%–
Q1 2023$13
-7.1%
12
+71.4%
0.00%–
Q4 2022$14–70.0%0.00%–
Q3 2022$0–7–0.00%–
 Download
Other shareholders
INMED PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
TD Waterhouse Canada Inc. 85$1250.00%
ROYAL BANK OF CANADA 11$00.00%
Advisory Services Network, LLC 6$60.00%
TCI Wealth Advisors, Inc. 5$60.00%
UBS Group AG 2,622$2,8320.00%
AllSquare Wealth Management LLC 21$230.00%
OSAIC HOLDINGS, INC. 41$430.00%
BANK OF AMERICA CORP /DE/ 1,822$1,9680.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
TORONTO DOMINION BANK 2$00.00%
View complete list of INMED PHARMACEUTICALS INC shareholders